Marlin Business Services Corp. (MRLN) Is At $25.00 Formed Wedge, Ghost Tree Capital Has Decreased Veracyte (VCYT) Stake

July 17, 2017 - By Adrian Mccoy

Ghost Tree Capital Llc decreased Veracyte Inc (VCYT) stake by 45.05% reported in 2016Q4 SEC filing. Ghost Tree Capital Llc sold 164,000 shares as Veracyte Inc (VCYT)’s stock rose 2.87%. The Ghost Tree Capital Llc holds 200,000 shares with $1.55M value, down from 364,000 last quarter. Veracyte Inc now has $264.92 million valuation. The stock decreased 1.37% or $0.11 on July 14, reaching $7.93. About shares traded. Veracyte Inc (NASDAQ:VCYT) has risen 56.46% since July 17, 2016 and is uptrending. It has outperformed by 39.76% the S&P500.

Marlin Business Services Corp. (MRLN) formed wedge up with $26.00 target or 4.00% above today’s $25.00 share price. Marlin Business Services Corp. (MRLN) has $315.32 million valuation. The stock increased 0.40% or $0.1 on July 14, reaching $25. About shares traded. Marlin Business Services Corp. (NASDAQ:MRLN) has risen 74.77% since July 17, 2016 and is uptrending. It has outperformed by 58.07% the S&P500.

Investors sentiment decreased to 1 in Q4 2016. Its down 1.20, from 2.2 in 2016Q3. It is negative, as 8 investors sold Marlin Business Services Corp. shares while 30 reduced holdings. 9 funds opened positions while 29 raised stakes. 9.39 million shares or 0.32% more from 9.36 million shares in 2016Q3 were reported. The New York-based Alliancebernstein Ltd Partnership has invested 0% in Marlin Business Services Corp. (NASDAQ:MRLN). American Grp Inc Inc invested in 0% or 4,763 shares. Bank Of Montreal Can owns 2,062 shares for 0% of their portfolio. Goldman Sachs Group Inc Inc, a New York-based fund reported 204,199 shares. 25,958 were reported by Acadian Asset Mngmt Ltd Liability. 48,868 are owned by Morgan Stanley. Geode Management Ltd Liability Corporation holds 0% or 126,281 shares. Barclays Public Limited Company holds 0% in Marlin Business Services Corp. (NASDAQ:MRLN) or 100 shares. 156,019 were reported by Dalton Greiner Hartman Maher And Comm. Mutual Of America Mngmt Ltd Liability has 220,973 shares for 0.09% of their portfolio. Blackrock Limited Liability holds 4,946 shares or 0% of its portfolio. Numeric Investors Lc has invested 0.03% in Marlin Business Services Corp. (NASDAQ:MRLN). The United Kingdom-based Blackrock Grp Limited has invested 0% in Marlin Business Services Corp. (NASDAQ:MRLN). Tiaa Cref Invest Management Lc holds 27,168 shares or 0% of its portfolio. Blackrock Fund Advsrs accumulated 0% or 275,026 shares.

Since January 31, 2017, it had 0 insider purchases, and 2 insider sales for $39,947 activity. Sherlock James sold 500 shares worth $11,125.

Analysts await Marlin Business Services Corp. (NASDAQ:MRLN) to report earnings on July, 27 after the close. They expect $0.36 EPS, 0.00% or $0.00 from last year’s $0.36 per share. MRLN’s profit will be $4.54 million for 17.36 P/E if the $0.36 EPS becomes a reality. After $0.34 actual EPS reported by Marlin Business Services Corp. for the previous quarter, Wall Street now forecasts 5.88% EPS growth.

Among 2 analysts covering Marlin Business Services (NASDAQ:MRLN), 1 have Buy rating, 0 Sell and 1 Hold. Therefore 50% are positive. Marlin Business Services had 3 analyst reports since November 4, 2015 according to SRatingsIntel. The stock of Marlin Business Services Corp. (NASDAQ:MRLN) has “Market Perform” rating given on Thursday, February 4 by William Blair.

Ghost Tree Capital Llc increased Neuroderm Ltd stake by 199,000 shares to 330,000 valued at $7.33M in 2016Q4. It also upped Inotek Pharmaceuticals Corp (Call) stake by 279,300 shares and now owns 300,000 shares. Dbv Technologies S A was raised too.

Investors sentiment increased to 3.5 in Q4 2016. Its up 1.50, from 2 in 2016Q3. It is positive, as 3 investors sold VCYT shares while 11 reduced holdings. 20 funds opened positions while 29 raised stakes. 39.11 million shares or 150.74% more from 15.60 million shares in 2016Q3 were reported. Renaissance Limited Liability Corporation holds 0% of its portfolio in Veracyte Inc (NASDAQ:VCYT) for 216,900 shares. Bridgeway Cap Management has invested 0.01% in Veracyte Inc (NASDAQ:VCYT). Sabby Mngmt Limited Liability Company holds 0.09% or 193,999 shares in its portfolio. Schwab Charles Investment Management holds 0% of its portfolio in Veracyte Inc (NASDAQ:VCYT) for 23,200 shares. 183,980 are held by Northern Corp. 148,600 were reported by California Public Employees Retirement Systems. Manufacturers Life Insur The owns 13,289 shares. 14,248 were reported by Rhumbline Advisers. Strs Ohio has invested 0% in Veracyte Inc (NASDAQ:VCYT). 10,737 are held by Tfs Lc. Acuta Cap Limited Liability Com has invested 10.11% of its portfolio in Veracyte Inc (NASDAQ:VCYT). Moreover, Cannell Lc has 2.67% invested in Veracyte Inc (NASDAQ:VCYT). Tiaa Cref Invest Mngmt Lc, a New York-based fund reported 49,100 shares. The New York-based Blackrock Inc has invested 0% in Veracyte Inc (NASDAQ:VCYT). Millennium Management Lc stated it has 404,127 shares.

Since March 21, 2017, it had 0 insider purchases, and 2 sales for $63,421 activity. Shares for $17,986 were sold by TREU JESSE I. Anderson Bonnie H sold $45,435 worth of Veracyte Inc (NASDAQ:VCYT) on Tuesday, March 21.

Among 4 analysts covering Veracyte (NASDAQ:VCYT), 4 have Buy rating, 0 Sell and 0 Hold. Therefore 100% are positive. Veracyte had 6 analyst reports since August 14, 2015 according to SRatingsIntel. The firm has “Buy” rating by BTIG Research given on Friday, August 14. The firm has “Buy” rating by Cantor Fitzgerald given on Friday, December 18. The stock of Veracyte Inc (NASDAQ:VCYT) has “Overweight” rating given on Friday, August 14 by Piper Jaffray. The rating was upgraded by Janney Capital to “Buy” on Tuesday, November 29.

Analysts await Veracyte Inc (NASDAQ:VCYT) to report earnings on August, 2. They expect $-0.25 EPS, up 37.50% or $0.15 from last year’s $-0.4 per share. After $-0.24 actual EPS reported by Veracyte Inc for the previous quarter, Wall Street now forecasts 4.17% negative EPS growth.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our daily email newsletter.





Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: